- Home
- CHI vs ACHC Comparison
CHI vs ACHC Comparison
Compare CHI & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHI | ACHC |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2002 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CHI | ACHC |
|---|---|---|
| Price | $12.72 | $23.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | 165.1K | ★ 2.8M |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 9.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $3,312,769,000.00 |
| Revenue This Year | N/A | $5.08 |
| Revenue Next Year | N/A | $5.98 |
| P/E Ratio | ★ N/A | $475.40 |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $10.00 | $11.43 |
| 52 Week High | $12.75 | $30.20 |
Technical Indicators
Market Signals| Indicator | CHI | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 40.03 |
| Support Level | $10.84 | $21.82 |
| Resistance Level | N/A | $24.47 |
| Average True Range (ATR) | 0.25 | 1.09 |
| MACD | 0.03 | -0.27 |
| Stochastic Oscillator | 97.28 | 16.07 |
Price Performance
Historical ComparisonAbout CHI Calamos Convertible Opportunities and Income Fund
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.